Disease
ORAL
COMPOUND
Discovery
Preclinical
Phase 1
Phase 2
Neuromuscular:Sarcopenia
MF-300
Spinal Muscular Atrophy
Not Disclosed
Fibrotic:Idiopathic Pulmonary Fibrosis
Not Disclosed

Pipeline Expansion

Neuromuscular
Bone
Fibrosis
Neuroinflammation